Skip to main content
Terug
Watch Compare

Meihua International Medical Technologies Co., Ltd.

Datakwaliteit: 83%
MHUAF
OTC Manufacturing Measuring & Analyzing Instruments
€ 6,41
€ 0,00 (0,00%)
Marktkapitalisatie: 5,48 M
Prijs
€ 6,41
Marktkapitalisatie
5,48 M
Dagbereik
€ 6,41 — € 6,41
52-Weeksbereik
€ 2,05 — € 64,00
Volume
1
Openen € 6,41
50D / 200D Gem.
€ 9,21
30,39% below
50D / 200D Gem.
€ 23,70
72,96% below

Quick Summary

Belangrijkste Punten

Debt/Equity of 0,07 — conservative balance sheet
Generating 3,59 M in free cash flow
P/E of 0,59 — trading at a low valuation

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)-6,73%
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
5,90%
Boven sectorgemiddelde (-53,41%)
ROIC5,61%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
0,07
Onder sectorgemiddelde (0,31)
Current Ratio5,71
Interest Coverage48,36

Waardering

PE (TTM)
0,59
Boven sectorgemiddelde (-1,48)
P/B Ratio0,03
EV/EBITDA1,45
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E 0,6 -1,5
P/B 0,0 1,6
ROE % 5,9 -53,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E 0,1 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) -6,73% Earnings Growth (3Y) 31,79%
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) 9,27 M
ROE 5,90% ROA 5,02%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) 3,59 M
ROIC 5,61% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,07 Current Ratio 5,71
Interest Coverage 48,36 Asset Turnover N/A
Working Capital 120,70 M Tangible Book Value 164,50 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 0,59 Forward P/E N/A
P/B Ratio 0,03 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 1,45 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 65,37%
Market Cap 5,48 M Enterprise Value 16,93 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share 4,19 OCF / Share 4,35
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 38,67%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021
Revenue — — 103,35 M 104,04 M
Net Income 10,84 M 11,63 M 6,24 M 20,95 M
EPS (Diluted) — 0,49 0,27 —
Gross Profit 33,30 M 33,20 M 38,10 M 39,81 M
Operating Income 14,31 M 14,67 M 10,80 M 26,26 M
EBITDA — — — —
R&D Expenses 3,46 M 2,75 M 2,96 M 2,73 M
SG&A Expenses — — — —
D&A — — 541.265,0 595.522,0
Interest Expense 247.615,0 3.468,0 191.198,0 180.744,0
Income Tax 2,79 M 3,46 M 4,71 M 5,28 M

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021
Total Assets 186,24 M 171,92 M 163,58 M 136,86 M
Total Liabilities 27,26 M 25,08 M 24,90 M 29,09 M
Shareholders' Equity 158,98 M 146,33 M 138,12 M 107,77 M
Total Debt 7,95 M 8,05 M 6,09 M 5,18 M
Cash & Equivalents — 16,93 M 26,74 M 8,15 M
Current Assets 143,44 M 132,24 M 135,32 M 97,28 M
Current Liabilities 27,26 M 25,07 M 24,17 M 29,09 M